Cargando…
Association between CYP2D6 Genotypes and the Risk of Antidepressant Discontinuation, Dosage Modification and the Occurrence of Maternal Depression during Pregnancy
Importance: Polymorphic expression of drug metabolizing enzymes affects the metabolism of antidepressants, and thus can contribute to drug response and/or adverse events. Pregnancy itself can affect CYP2D6 activity with profound variations determined by CYP2D6 genotype. Objective: To investigate the...
Autores principales: | Bérard, Anick, Gaedigk, Andrea, Sheehy, Odile, Chambers, Christina, Roth, Mark, Bozzo, Pina, Johnson, Diana, Kao, Kelly, Lavigne, Sharon, Wolfe, Lori, Quinn, Dee, Dieter, Kristen, Zhao, Jin-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511844/ https://www.ncbi.nlm.nih.gov/pubmed/28769788 http://dx.doi.org/10.3389/fphar.2017.00402 |
Ejemplares similares
-
Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case–control study
por: Dandjinou, Maëlle, et al.
Publicado: (2019) -
Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort
por: Bérard, Anick, et al.
Publicado: (2017) -
The Quebec Pregnancy Cohort – Prevalence of Medication Use during Gestation and Pregnancy Outcomes
por: Bérard, Anick, et al.
Publicado: (2014) -
Medically assisted reproduction and the risk of being born small and very small for gestational age: Assessing prematurity status as an effect modifier
por: Gorgui, Jessica, et al.
Publicado: (2022) -
Long-Distance Phasing of a Tentative “Enhancer” Single-Nucleotide Polymorphism With CYP2D6 Star Allele Definitions
por: Boone, Erin C., et al.
Publicado: (2020)